KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Other financing activities (2020 - 2022)

Historic Other financing activities for Nektar Therapeutics (NKTR) over the last 5 years, with Q1 2022 value amounting to $750000.0.

  • Nektar Therapeutics' Other financing activities changed 0.0% to $750000.0 in Q1 2022 from the same period last year, while for Dec 2022 it was $750000.0, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $750000.0 for FY2022, which is 7500.0% down from last year.
  • As of Q1 2022, Nektar Therapeutics' Other financing activities stood at $750000.0, which was down 0.0% from $750000.0 recorded in Q4 2021.
  • Over the past 5 years, Nektar Therapeutics' Other financing activities peaked at $146.2 million during Q4 2020, and registered a low of $750000.0 during Q1 2021.
  • Its 3-year average for Other financing activities is $25.0 million, with a median of $750000.0 in 2021.
  • In the last 5 years, Nektar Therapeutics' Other financing activities crashed by 9948.72% in 2021 and then changed by 0.0% in 2022.
  • Over the past 3 years, Nektar Therapeutics' Other financing activities (Quarter) stood at $146.2 million in 2020, then crashed by 99.49% to $750000.0 in 2021, then changed by 0.0% to $750000.0 in 2022.
  • Its Other financing activities stands at $750000.0 for Q1 2022, versus $750000.0 for Q4 2021 and $750000.0 for Q3 2021.